0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes

Buy Now

Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development - A Focus on Early Phase Clinical Studies (Paperback, Softcover reprint of the original 1st ed. 2015) Loot Price: R4,547
Discovery Miles 45 470
Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development - A Focus on Early Phase Clinical...

Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development - A Focus on Early Phase Clinical Studies (Paperback, Softcover reprint of the original 1st ed. 2015)

Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch

 (sign in to rate)
Loot Price R4,547 Discovery Miles 45 470 | Repayment Terms: R426 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The world is beset by a pandemic of obesity and type 2 diabetes and the need for new drugs is startlingly clear; recent years have seen a huge increase in research activity to fill this gap. The development of new drugs for diabetes and obesity must be founded upon a sound appreciation of the pathophysiology of these common disorders. The dual defects of insulin resistance and impaired insulin secretion are fundamental to the pathogenesis and progression of obesity-associated type 2 diabetes. There is a need to explain how new drugs can counter insulin resistance and insulin deficiency to a broad range of professionals, from clinical scientists active in early (and later) phase drug development to specialist physicians and increasingly primary care doctors who must tailor drug regimens to the individual patient. Clinical research methods for measuring insulin action and insulin secretion have become well-established in proof-of-mechanism studies; however, selection of the best techniques is by no means straightforward. The purpose of the book is to aid the selection of the most appropriate techniques for assessing insulin action, insulin secretion and body composition in humans (with particular reference to new drugs) in phase 1 and 2 studies and aid the understanding of drug effects and non-drug treatment strategies on key biochemical-hormonal defects of obesity and type 2 diabetes. The book will assume a working knowledge of human physiology relating to glucose metabolism and will be of interest to biomedical scientists, pharmacologists, academics involved in metabolic research and clinicians practicing in these specialties.

General

Imprint: Springer London
Country of origin: United Kingdom
Release date: September 2016
First published: 2015
Editors: Andrew J. Krentz • Lutz Heinemann • Marcus Hompesch
Dimensions: 254 x 178 x 17mm (L x W x T)
Format: Paperback
Pages: 312
Edition: Softcover reprint of the original 1st ed. 2015
ISBN-13: 978-1-4471-7032-7
Languages: English
Subtitles: English
Categories: Books > Medicine > General issues > General
Books > Medicine > Pre-clinical medicine: basic sciences > Physiology > Metabolism
Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Promotions
LSN: 1-4471-7032-6
Barcode: 9781447170327

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners